Slipetz D, Buchanan S, Mackereth C, Brewer N, Pellow V, Hao C, Adam M, Abramovitz M, Metters K M
Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, 16711 Transcanada Hwy, H9H-3L1, Kirkland, Quebec, Canada.
Biochem Pharmacol. 2001 Oct 15;62(8):997-1012. doi: 10.1016/s0006-2952(01)00742-0.
The prostaglandin E2 (PGE2) EP4 subtype is one of four prostanoid receptors that use PGE2 as the preferred ligand. We have investigated the agonist-mediated regulation of EP4 using a multifaceted approach. Short-term (30 min) agonist challenge of recombinant EP4 expressed in human embryonic kidney 293 cells (EP4-HEK293 cells) with PGE2 (1 microM) resulted in the desensitization of intracellular cyclic AMP (cAMP) accumulation and a reduction in cell surface [3H]PGE2 specific binding sites. These events correlated with sequestration of EP4, as visualized by immunofluorescence confocal microscopy and phosphorylation, as shown by [32P]orthophosphate labeling of the receptor. Stimulation of protein kinase A activity in EP4-HEK293 cells (10 microM forskolin or 1 mM 8-bromo-cAMP) did not induce EP4 desensitization, sequestration, or phosphorylation. In contrast, stimulation of protein kinase C activity (100 nM phorbol 12-myristate 13-acetate) attenuated PGE2-induced adenylyl cyclase activity and increased EP4 phosphorylation, but did not induce sequestration or a reduction in [3H]PGE2 specific binding sites. EP4 receptors containing a third intracellular loop deletion [EP4 (del. 215-263)] or a carboxyl-terminal tail truncation [EP4 (del. 355)] of EP4 were used to demonstrate that the C-terminal tail governs sequestration as well as phosphorylation of the receptor.
前列腺素E2(PGE2)的EP4亚型是四种以PGE2为首选配体的类前列腺素受体之一。我们采用多方面的方法研究了激动剂介导的EP4调节作用。用PGE2(1微摩尔)对人胚肾293细胞(EP4-HEK293细胞)中表达的重组EP4进行短期(30分钟)激动剂刺激,导致细胞内环磷酸腺苷(cAMP)积累脱敏,细胞表面[3H]PGE2特异性结合位点减少。这些事件与EP4的隔离相关,这通过免疫荧光共聚焦显微镜观察到,并且与磷酸化相关,如受体的[32P]正磷酸盐标记所示。刺激EP4-HEK293细胞中的蛋白激酶A活性(10微摩尔福斯高林或1毫摩尔8-溴-cAMP)不会诱导EP4脱敏、隔离或磷酸化。相反,刺激蛋白激酶C活性(100纳摩尔佛波醇12-肉豆蔻酸酯13-乙酸酯)会减弱PGE2诱导的腺苷酸环化酶活性并增加EP4磷酸化,但不会诱导隔离或[3H]PGE2特异性结合位点减少。含有EP4第三个细胞内环缺失[EP4(缺失215-263)]或羧基末端尾巴截短[EP4(缺失355)]的EP4受体被用于证明C末端尾巴控制受体的隔离以及磷酸化。